Skip to main content

Kodiak Sciences Inc.

For the period ended Dec 31, 2025. Filed Mar 31, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 31, 2026

KOD$108.06+0.9%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Consolidated Statements of Stockholders’ Equity

Common Stock · AdditionalPaid-In · AccumulatedOtherComprehensive · Accumulated · TotalStockholders’
SharesAmountCapitalIncome (Loss)DeficitEquity
Balances at December 31, 202252,333,850$5$1,329,509$(1,307)$(892,040)$436,167
Exercise of stock options7,528—60——60
Restricted stock units vested116,403—————
Proceeds from ESPP50,821—182——182
Stock-based compensation——88,556——88,556
Other comprehensive income———1,307—1,307
Net loss————(260,491)(260,491)
Balances at December 31, 202352,508,60251,418,307—(1,152,531)265,781
Exercise of stock options82,790—394——394
Restricted stock units vested86,559—————
Proceeds from ESPP48,965—107——107
Stock-based compensation——60,213——60,213
Net loss————(176,207)(176,207)
Balances at December 31, 202452,726,91651,479,021—(1,328,738)150,288
Exercise of stock options925,813—5,363——5,363
Proceeds from public offering, net of offering costs8,000,0001172,655——172,656
Restricted stock units vested45,190—————
Proceeds from ESPP60,535—180——180
Stock-based compensation——58,863——58,863
Net loss————(229,967)(229,967)
Balances at December 31, 202561,758,454$6$1,716,082$—$(1,558,705)$157,383
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.